These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7625884)
41. Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery. Yokoyama T; Okada Y; Jinno Y; Izumi H; Izawa T; Ogawa N Gen Pharmacol; 1994 Sep; 25(5):941-5. PubMed ID: 7835641 [TBL] [Abstract][Full Text] [Related]
42. Pharmacological properties of KRN2391, a novel vasodilator of the nitrate-potassium channel opener hybrid type. Ogawa N Gen Pharmacol; 1994 Jul; 25(4):609-16. PubMed ID: 7958718 [TBL] [Abstract][Full Text] [Related]
43. Enhancement of the vasorelaxant potency of nicorandil by metabolic inhibition and adenosine in the pig coronary artery. Davie CS; Standen NB Cardiovasc Res; 1998 Mar; 37(3):791-8. PubMed ID: 9659464 [TBL] [Abstract][Full Text] [Related]
44. Nicorandil, its denitrated metabolite, SG-86 and naturally occurring vasodilators synergistically interact on adenosine-induced vasodepression in rats: special reference to adrenomedullin. Sakai K; Saito K Fundam Clin Pharmacol; 1999; 13(1):27-33. PubMed ID: 10027085 [TBL] [Abstract][Full Text] [Related]
45. Vasodilating properties of KRN2391: structural basis of a new pyridine-type potassium channel opener with a nitrate moiety. Ishibashi T; Hamaguchi M; Imai S Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):94-101. PubMed ID: 1357559 [TBL] [Abstract][Full Text] [Related]
46. Nicorandil (2-nicotinamidoethyl nitrate) inhibits both vaso-dilating and -constricting effects of endothelin in a vascularly isolated hind-limb preparation in rats. Nishimura M; Takahashi H; Sakamoto M; Ikegaki I; Nakanishi T; Yoshimura M Jpn Circ J; 1991 Jul; 55(7):729-36. PubMed ID: 1831867 [TBL] [Abstract][Full Text] [Related]
47. Interrelationship of cardiovascular effects, plasma levels of nicorandil, and vascular cGMP formation in conscious rats. Sakai K; Akima M; Kamachi S; Moriyasu M; Kitajima S J Pharm Pharmacol; 1998 Jun; 50(6):661-6. PubMed ID: 9680078 [TBL] [Abstract][Full Text] [Related]
48. Synergism between low-dose nicorandil and neuropeptides on adenosine-induced vasodepression in rats. Sakai K; Saito K Eur J Pharmacol; 1998 Jul; 352(2-3):229-36. PubMed ID: 9716359 [TBL] [Abstract][Full Text] [Related]
49. Effects of N-(2-hydroxyethyl)nicotinamide nitrate (nicorandil; SG-75) and its derivatives on pancreatic exocrine secretion in the dog. Yonekura H; Iwatsuki K; Horiuchi A; Chiba S Pancreas; 1990; 5(1):75-81. PubMed ID: 1688393 [TBL] [Abstract][Full Text] [Related]
50. Cyanoamidines. II. Synthesis and pharmacological activity of N-arylalkyl-N'-cyano-3-pyridinecarboxamidines. Nakajima T; Nakajima S; Izawa T; Kashiwabara T; Munezuka Y Chem Pharm Bull (Tokyo); 1994 Dec; 42(12):2483-90. PubMed ID: 7697763 [TBL] [Abstract][Full Text] [Related]
51. The pharmacokinetics and haemodynamic effects of continuous nicorandil infusion in healthy volunteers. Wolf DL; Hearron AE; Metzler CM; Ferry JJ; Froeschke MO; Luderer JR Eur J Clin Pharmacol; 1993; 45(5):437-43. PubMed ID: 8112373 [TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamic and metabolism studies on a new coronary vasodilator, N-(2-hydroxyethyl) nicotinamide nitrate (SG-75). Sakai K; Ohba Y; Akima M; Kamiyama H; Hinohara Y; Nakano H Jpn J Pharmacol; 1980 Dec; 30(6):881-90. PubMed ID: 6454019 [TBL] [Abstract][Full Text] [Related]
53. Effect of K+ channel openers, KRN2391 and Ki1769, and nitroglycerin on the urinary tract of rats in vivo. Kontani H; Jinkawa M; Shiraoya C; Nagashima A Jpn J Pharmacol; 1999 Jun; 80(2):143-53. PubMed ID: 10440533 [TBL] [Abstract][Full Text] [Related]
54. Nicorandil affects diurnal rhythms of body temperature, heart rate and locomotor activity in rats. Gantenbein M; Attolini L; Bruguerolle B Eur J Pharmacol; 1998 Apr; 346(2-3):125-30. PubMed ID: 9652351 [TBL] [Abstract][Full Text] [Related]
55. A modified product inhibition model describes the nonlinear pharmacokinetics of nicorandil in rats. Bachert EL; Li ZW; Zhao L; Chung SJ; Fung HL Pharm Res; 1994 Aug; 11(8):1190-8. PubMed ID: 7971723 [TBL] [Abstract][Full Text] [Related]
56. Effects of adenosine triphosphate dependent potassium channel opener on bladder overactivity in rats with cerebral infarction. Nakamura Y; Kontani H; Tanaka T; Komatsu K; Namiki M; Yokoyama O J Urol; 2002 Nov; 168(5):2275-9. PubMed ID: 12394774 [TBL] [Abstract][Full Text] [Related]
57. Effect of acute and chronic immobilization stress on plasma levels of nicorandil administered orally to rats. Yamori M; Oishi R; Gomita Y; Saeki K Acta Med Okayama; 1994 Apr; 48(2):113-5. PubMed ID: 8042535 [TBL] [Abstract][Full Text] [Related]
58. [Hypertensive action of 5-(beta-aminoethyl)aminoisoxazoles: synthesis and screening of isoxazolopyrazines and isoxazolodiazepines]. Dannhardt G; Dominiak P; Laufer S Arch Pharm (Weinheim); 1991 Mar; 324(3):141-8. PubMed ID: 1859249 [TBL] [Abstract][Full Text] [Related]
59. [Vasodilator effect of several series of pyridine derivatives]. TRCKA V; VEJDELEK ZJ Pharmazie; 1956 Apr; 11(4):242-7. PubMed ID: 13322628 [No Abstract] [Full Text] [Related]
60. The synthesis of pyridine derivatives possessing possible emetic and rodenticidal activity. JONES WD; JENKINS GL; CHRISTIAN JE J Am Pharm Assoc Am Pharm Assoc; 1949 Feb; 38(2):70-2. PubMed ID: 18111457 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]